PF-07820435

N/A

Report date: 2024/06/05 13:55:13

Base Information

Drug NamePF-07820435
Drug Alias NamePF-07820435
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStimulator of interferon genes stimulants
TargetsStimulator of interferon genes
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoMainland China +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPfizer Investment Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsCarcinoma, Transitional Cell +[8] 

Other Information

ATC CodeN/A
Related LinksN/A